An expert panel voted 13-10 Tuesday recommending the U.S. Food and Drug Administration grant emergency use authorization to a new drug developed by Merck to treat mild to moderate COVID-19 in unvaccinated patients. Read more» 
Special thanks
to our supporters
- NewsMatch
- John S. and James L. Knight Foundation
- Ida B. Wells
- Fund for Investigative Journalism
- Edna Gray
- Tucson Police Department
- Ann-Eve Dingell
- Margaret Fuller
- Linda Seberger
- Maggie Golston
- Edward Smith
- & many more!
We rely on readers like you. Join them & contribute to the Sentinel today!
Hosting provider
Proud member of
The FDA’s 19-member Vaccines and Related Biological Products Advisory Committee voted unanimously Friday to recommend that everyone who received the COVID-19 vaccine developed by Johnson and Johnson receive a second dose at least two months after the first jab. Read more»
election
legislature
republicans
aztecs
pcc
congress
joe biden
coronavirus
supreme court
health care
pima county
donald trump
cbp
immigration
budget
democrats
ua
taxes
border patrol
jobs
senate
drugs
ice
economy
texas